The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Fact checked by Jennifer Klump A group of advisors to the Centers for Disease Control and Prevention (CDC) voted 5-2 to ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new preventive shot against ...

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...

Common RSV symptoms in many people include "a runny nose, cough, sneezing and fever – basically mild cold-like symptoms that are mostly contained to the upper respiratory tract," says Dr. Alison ...

Common RSV symptoms in many people include "a runny nose, cough, sneezing and fever – basically mild cold-like symptoms that are mostly contained to the upper respiratory tract," says Dr. Alison ...

Is this your child's symptom? Your child has been diagnosed with bronchiolitis It's an infection of the smallest airways in the lungs Caused by a virus called RSV (respiratory syncytial virus) ...

Wednesday, February 5, 2025 It's peak respiratory illness season in the Triangle, with hospitals seeing a "trifecta" of winter viruses - COVID-19, RSV and the flu.

Respiratory syncytial virus (RSV) causes substantial seasonal morbidity and mortality in older adults with chronic medical conditions. 1–4 In May, 2023, two new vaccine products were approved by the ...